UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
May 23, 2023

SANUWAVE Health, Inc.
(Exact name of registrant as specified in its charter)

Nevada
 
000-52985
 
20-1176000
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

11495 Valley View Road, Eden Prairie, Minnesota
 
55344
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code
(770) 419-7525

N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which
registered
N/A
 
N/A
 
N/A
Indicate by check mark whether the registration is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective May 23, 2023, the Board of Directors (the “Board”) of SANUWAVE Health, Inc. (the “Company”) appointed Morgan Frank, age 51, the current Chairman of the Board, as the Company’s interim Chief Executive Officer. Mr. Frank, who joined the board as Chairman in August 2022, is a founder and principal at Manchester Explorer Fund (18 years) and at Manchester Explorer Ltd (Cayman), two life science focused public equity hedge funds specializing in hands-on microcap growth and development companies.  He also sits on the board of directors of Modular Medical, Inc. (MODD), a development stage company focused on next generation insulin delivery.

In connection with his appointment as interim Chief Executive Officer, the Company and Mr. Frank entered into an Executive Employment Agreement, effective May 23, 2023 (the “Employment Agreement”). Pursuant to the Employment Agreement, Mr. Frank will be paid a de minimis base salary of $1.00 per year, may be eligible to receive an incentive bonus opportunity in accordance with any criteria determined by the Board, and will be entitled to participate in the Company’s employee benefit plans and programs. Mr. Frank’s employment will be terminated upon (i) written notice of termination or resignation by either the Company or Mr. Frank, respectively, for any reason, provided that Mr. Frank must provide at least 60 days’ prior notice of his resignation, or (ii) Mr. Frank’s death or disability. Moreover, during the term of his employment and for a period of one year thereafter, Mr. Frank agreed (i) not to perform services for or have any interest in any competitive business and (ii) not to solicit (a) the Company’s current or former employees or independent contractors or (b) actual or prospective customers, clients, vendors, service providers, suppliers or contractors. Finally, the Employment Agreement also includes customary confidentiality and non-disparagement provisions. The foregoing summary of the Employment Agreement is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Mr. Frank has no family relationship with any director or executive officer of the Company.  A description of each transaction in which Mr. Frank had a direct or indirect material interest that is required to be disclosed pursuant to Item 404(a) of Regulation S-K is included under “Item 13. Certain Relationships and Related Transactions, and Directors Independence—Related Party Transactions” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and is incorporated herein by reference.

Mr. Frank will succeed Kevin A. Richardson, II, the former Chief Executive Officer of the Company, who stepped down as Chief Executive Officer on May 23, 2023 to serve as the Company’s Chief Strategy Officer.  Mr. Richardson will remain a member of the Board.

On May 23, 2023, the Company and Mr. Richardson entered into a Transition and Separation Agreement (the “Transition Agreement”), pursuant to which Mr. Richardson will serve as the Company’s Chief Strategy Officer for an anticipated period of 12 months or alternatively a consulting agreement for a period of two years.  Mr. Richardson will continue to receive his current salary or an equivalent consulting fee, remain eligible for the Company’s group health benefit plans and programs, unless he earlier becomes eligible for health insurance benefits through a subsequent employer or exceeds the legal eligibility period for continued coverage,  and will remain eligible to receive a pro-rated annual bonus, one-third of which will be based upon the Company achieving each of the following metrics during calendar year 2023: (i) sales of $30 million, (ii) adjusted EBITDA of $3 million and (iii) listing on The Nasdaq Stock Market or the New York Stock Exchange.  Mr. Richardson also is entitled to receive options exercisable for 25 million shares of the Company’s common stock, one-half of which will vest immediately and one-half of which will vest on April 15, 2024. During any period of continued service with the Company, Mr. Richardson’s options will continue to vest.  If no mutually agreed upon employment agreement or consulting agreement is entered into, or if Mr. Richardson is terminated without cause prior to the end of the anticipated transition period, Mr. Richardson will receive a severance payment equal to 20 weeks of his most recent base salary, subject to Mr. Richardson executing a release of claims in favor of the Company and his continued compliance with the Transition Agreement and any post-employment obligations under any employee agreements between the Company and Mr. Richardson. The Transition Agreement also includes a release of claims in favor of the Company and customary confidentiality and non-disparagement provisions. The foregoing summary of the Transition Agreement is qualified in its entirety by reference to the full text of the Transition Agreement, a copy of which is filed as Exhibit 10.2 hereto and incorporated herein by reference.


Item 7.01
Regulation FD Disclosure.

On May 24, 2023, the Company issued a press release announcing the leadership transition described in Item 5.02 above. A copy of the press release is attached hereto as Exhibit 99.1.

The information in this Item 7.01, and Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits.

Exhibit
No.
 
Description
     
 
Executive Employment Agreement, effective May 23, 2023, by and between the Company and Morgan Frank
 
Transition and Separation Agreement, dated May 23, 2023, by and between the Company and Kevin A. Richardson, II
 
Press Release dated May 24, 2023
104
 
Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
SANUWAVE HEALTH, INC.
     
Dated: May 30, 2023
By:
/s/ Toni Rinow
 
Name:
Toni Rinow
 
Title:
Chief Financial Officer




Exhibit 10.1

EXECUTIVE EMPLOYMENT AGREEMENT
 
This Executive Employment Agreement (“Agreement”) is effective as of May 23, 2023 (the “Effective Date”), by and between SANUWAVE Health, Inc., a Nevada corporation (the “Company”), and Morgan Frank (the “Executive”).
 
RECITALS
 
WHEREAS, the Company desires to employ Executive and Executive desires to accept engagement by the Company as its Chief Executive Officer on the terms outlined in this Agreement; and
 
WHEREAS, in connection with Executive’s employment with the Company, Executive has had, and will have, access to confidential, proprietary and trade secret information of the Company, which confidential, proprietary and trade secret information the Company desires to protect from disclosure and unfair competition.
 
AGREEMENT
 
NOW, THEREFORE, in consideration of the foregoing premises and the respective agreements of the Company and Executive set forth below, the Company and Executive, intending to be legally bound, agree as follows:
 
1.           Term of Employment. The term of Executive’s employment under this Agreement will commence on the Effective Date, and will continue until Executive’s employment is terminated pursuant to Section 8 below (such period being the “Employment Term”).
 
2.            Position and Duties.
 
(a)          Employment with the Company. While Executive is engaged by the Company during the Employment Term, Executive shall report to the Company’s Board of Directors (the “Board”) and shall perform such duties and responsibilities for the Company and its Affiliates (defined below) as the Board shall assign to Executive from time to time consistent with Executive’s position. Executive’s title during the Employment Term shall be Chief Executive Officer. For purposes of this Agreement, “Affiliate” means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, or an unincorporated organization, that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Company.
 
(b)          Performance of Duties and Responsibilities. Executive shall serve the Company faithfully and to the best of Executive’s ability and shall devote Executive’s working time, attention and efforts to the business of the Company during Executive’s employment with the Company. Executive will follow and comply with applicable policies and procedures adopted by the Company from time to time, including without limitation policies relating to business ethics, conflict of interest, non-discrimination, confidentiality and protection of trade secrets. Executive hereby represents and confirms that he is under no contractual or legal commitments that would prevent Executive from fulfilling Executive’s duties and responsibilities as set forth in this Agreement. Notwithstanding the foregoing, during Executive’s employment with the Company, Executive may participate in civic, religious and charitable activities and personal investment activities to a reasonable extent, and, serve on corporate boards or committees so long as such activities do not interfere with the performance of Executive’s duties and responsibilities hereunder.
 

3.          Board Position. During the Employment Term, Executive shall continue to serve in his role on the Company’s Board of Directors.  Executive acknowledges and agrees that Executive is not entitled to any additional compensation in respect of Executive’s continued appointment as a director of the Company. Executive agrees to abide by all statutory, fiduciary or common law duties arising under applicable law that apply to Executive as a director of the Company.
 
4            Compensation.
 
(a)         Base Salary. While Executive is employed by the Company during the Employment Term, the Company shall pay to Executive a base salary at the annual rate determined from time to time by the Company (the “Base Salary”), less all legally required and authorized deductions and withholdings, which Base Salary will be paid in accordance with the Company’s normal payroll policies and procedures. As of the Effective Date, Executive’s Base Salary is $1.00.
 
(b)        Incentive Compensation. During the Employment Term, Executive may be eligible to receive an incentive bonus opportunity in accordance with any criteria determined by the Board of Directors.
 
(d)        Employee Benefits. While Executive is employed by the Company during the Employment Term, Executive shall be entitled to participate in each employee benefit plan and program of the Company to the extent that Executive meets the eligibility requirements for such individual plan or program. Executive may receive other benefits commensurate with Executive’s position as may be approved from time to time by the Board of Directors.
 
(e)          Expenses. While Executive is employed by the Company during the Employment Term, the Company shall reimburse Executive for all reasonable and necessary out-of-pocket business, travel and entertainment expenses incurred by Executive in the performance of Executive’s duties and responsibilities hereunder, including without limitation cell phone costs and expenses incurred in connection with the business of the Company, subject to the Company’s normal policies and procedures for expense verification and documentation.
 
5.            Confidential Information.
 
(a)        Definition of Confidential Information. Except as expressly permitted by the Board in writing, Executive shall at all times keep confidential and not disclose, divulge, furnish or make accessible to anyone or use in any way other than in the ordinary course of the business of the Company, any confidential, proprietary, nonpublic or secret knowledge or information of the Company or any of its Affiliates that Executive acquires during Executive’s employment with the Company, whether developed by himself or by others, concerning (i) any trade secrets, (ii) any confidential, proprietary, nonpublic or secret design, process, formula, plan, model, specifications, device or material (whether or not patented or patentable) directly or indirectly useful in any aspect of the business of the Company or any of its Affiliates, (iii) any customer or supplier list of the Company or any of its Affiliates, or any requirements, specifications or other confidential information about or received from any customer or supplier, (iv) any confidential, proprietary, nonpublic or secret development or research work of the Company or any of its Affiliates, (v) any strategic or other business, marketing or sales plan of the Company or any of its Affiliates, (vi) any financial data or plan respecting the Company or any of its Affiliates, or (vii) any other confidential, nonpublic or proprietary information or secret aspects of the business of the Company or any of its Affiliates (“Confidential Information”).
 
2

(b)         Acknowledgement. Executive acknowledges that the above-described Confidential Information constitutes a unique and valuable asset of the Company and its Affiliates and represents a substantial investment of time and expense by the Company and its Affiliates, and that any disclosure or other use of such knowledge or information other than for the sole benefit of the Company would be wrongful and may cause irreparable harm to the Company and its Affiliates. The parties acknowledge and agree that Executive’s obligations under this Agreement to maintain the confidentiality of the Company’s Confidential Information are in addition to any obligations of Executive under applicable statutory or common law.
 
(c)         Exceptions. The foregoing obligations of confidentiality shall not apply to any Confidential Information to the extent that it (i) is now or subsequently becomes generally publicly known or generally known in the industry in which the Company operates, (ii) is independently made available to Executive in good faith by a third party who Executive reasonably believes has not violated an obligation of confidentiality to the Company or any of its Affiliates, or (iii) is required to be disclosed by legal process. Nothing contained in the preceding sentence shall be interpreted to legitimize any disclosure of Confidential Information by Executive that occurs outside of any of the events described in items (i) through (iii) of the preceding sentence.
 
(d)         Notice.  Executive may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (a) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney if such disclosure is made solely for the purpose of reporting or investigating a suspected violation of law or for pursuing an anti-retaliation lawsuit; or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal and Executive does not disclose the trade secret except pursuant to a court order.
 
6.           Ventures. If, during Executive’s employment with the Company, Executive is engaged in or associated with the planning or implementing of any project, program or venture involving the Company (or any of its Affiliates) and a third party or parties, all rights in such project, program or venture shall belong to the Company. Except as approved in writing by the Board, Executive shall not be entitled to any interest in any such project, program or venture or to any commission, finder’s fee or other compensation in connection therewith, other than the compensation to be paid to Executive by the Company as provided herein. Executive shall have no interest, direct or indirect, in any customer or supplier that conducts business with the Company (or any of its Affiliates), unless such interest has been disclosed in writing to and approved by the Board before such customer or supplier seeks to do business with the Company (or any of its Affiliates). Ownership by Executive, as a passive investment, of less than 1.0% of the outstanding shares of capital stock of any corporation traded on a national securities exchange or publicly traded in the over‑the‑counter market shall not constitute a breach of this Section 6.
 
3

7.            Patents, Copyrights and Related Matters.
 
(a)         Disclosure and Assignment. Executive shall promptly disclose to the Company any and all improvements, discoveries, processes, know-how, trade-secrets and inventions that Executive may conceive and/or reduce to practice individually or jointly or commonly with others (“Discoveries”) while he is employed with the Company or any of its Affiliates. Executive agrees to assign and does hereby immediately assign, transfer and set over to the Company Executive’s entire right, title and interest in and to any and all Discoveries, and in and to any and all intellectual property rights thereto. Executive agrees to execute all instruments deemed reasonably necessary by the Company to protect and perfect rights in and to the Discoveries. This Section 7(a) shall not apply to any invention for which no equipment, supplies, facilities, Confidential Information, or other trade secret information of the Company was used and that was developed entirely on Executive’s own time, and (i) that does not relate (A) directly to the business of the Company, or (B) to the Company’s actual or demonstrably anticipated research or development, or (ii) that does not result from any work performed by Executive for the Company.
 
(b)       Copyrightable Material. Executive hereby agrees to assign and does assign to the Company all right, title and interest in all copyrightable material (including intellectual property rights therein) that Executive conceives or originates individually or jointly or commonly with others, and that arise during the Employment Term with the Company or any of its Affiliates and out of the performance of Executive’s duties and responsibilities under this Agreement. Executive shall execute any and all papers and perform all other acts reasonably necessary to assist the Company to obtain and register copyrights on such materials. Where applicable, works of authorship created by Executive for the Company in performing Executive’s duties and responsibilities hereunder shall be considered “works made for hire,” as defined in the U.S. Copyright Act.
 
8.            Termination of Employment.
 
(a)          Executive’s employment with the Company shall terminate upon:
 
i.          the date specified in written notice as ratified by a majority of the Company’s Board of Directors to Executive notifying Executive of the termination of Executive’s employment for any reason;
 
ii.          Executive providing to the Company not less than 30 days’ prior written notice of Executive’s resignation of employment effective at the end of such period, provided that the Company may in its sole discretion elect to relieve Executive from Executive’s duties during all or any portion of the notice period; or
 
iii.          Executive’s death or Disability (defined below).
 
(b)          The date upon which Executive’s termination of employment with the Company is effective is the “Termination Date.”
 
(c)        Disability” hereunder shall mean the inability of Executive to perform on a full-time basis the duties and responsibilities of Executive’s employment with the Company by reason of Executive’s illness or other physical or mental impairment or condition, if such inability continues for an uninterrupted period of 90 days or more during any 180-day period. A period of inability shall be “uninterrupted” unless and until Executive returns to full-time work for a continuous period of at least 30 days.
 
4

(d)          In the event of termination of Executive’s employment, the sole obligation of the Company shall be its obligation to pay Executive any earned and unpaid compensation due to Executive as of the Executive’s Termination Date or as otherwise provided by law, and the Company shall have no other obligation to Executive or to Executive’s beneficiary or Executive’s estate.
 
9.           Non-Competition/Non-Solicitation. Executive acknowledges that the Company has spent significant time, effort and resources protecting its Confidential Information, including its trade secrets, customer goodwill, and employee, supplier, and vendor relationships. Executive has had access to the Company’s Confidential Information, and has significant control and influence over the Company’s customers, suppliers, vendors and employees, and he will continue to do so under this Agreement. In order to protect the Company’s Confidential Information, trade secrets, customer goodwill and the stability of the Company’s workforce, and other legitimate business interests, the Executive agrees to the following covenants:
 
(a)          Non-Competition. During Executive’s employment with the Company or any Affiliate and for a period of one (1) year following the termination of such employment, whether initiated by Executive or the Company, Executive shall not, either directly or indirectly in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, perform services for or have any interest in any Competitive Business in the Territory. “Competitive Business” means any person, entity or business operation (other than the Company) that engages in any business that is competitive with the then-current businesses of the Company or with any business or market the Company is actively preparing to enter as of the date of termination of Executive’s employment. Executive acknowledges that the Company conducts its business throughout the United States and internationally, and, therefore, that the term “Territory” as used herein shall be worldwide. Ownership by Executive, as a passive investment, of less than 1.0% of the outstanding shares of capital stock of any corporation traded on a national securities exchange or publicly traded in the over-the-counter market shall not constitute a breach of this Section 9(a).
 
(b)          Non-Solicitation of Customers and Suppliers. During Executive’s employment with the Company or any Affiliate and for a period of one (1) year following the termination of such employment, whether initiated by Executive or the Company, Executive shall not, either directly or indirectly on behalf of himself or any third party (i) call on or solicit any customers for the purpose of marketing or selling any products or services competitive with the business of the Company, or for the purpose of diverting any business away from the Company; (ii) persuade or attempt to persuade, or induce or attempt to induce, any actual or prospective customer, client, vendor, service provider, supplier, contractor or any other person having business dealings with the Company to cease doing business or otherwise transacting business with the Company or to reduce the amount of business it conducts or will conduct with the Company; (iii) call on or solicit any suppliers of the Company for the purpose of marketing or selling any products or services competitive with the business of the Company or for the purpose of attempting to persuade, induce or attempt to induce any supplier of the Company to cease doing business or otherwise transacting business with the Company or to reduce the amount of business it conducts or will conduct with the Company; or (iv) otherwise disrupt, damage or interfere in any manner with the relationship between the Company and its actual or prospective customers, clients, vendors, service providers, or suppliers. Executive acknowledges that the Company has invested material time and resources in the identification and qualification of its customers and/or suppliers and that the identity, nature and details of its relationships with customers and/or suppliers are unique and proprietary.
 
5

(c)          Non-Solicitation of Employees. During Executive’s employment with the Company or any Affiliate and for a period of one (1) year following the termination of such employment, whether initiated by the Executive or the Company, Executive shall not, either directly or indirectly on behalf of himself or any third party, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, hire, engage, recruit, solicit, or otherwise interfere with the employment or retention of any person who is then an employee or independent contractor of the Company or any of its Affiliates or who was an employee or independent contractor of the Company or any of its Affiliates as of the Termination Date. Anonymous job postings in a general publication or website to which an employee responds shall not violate this Section 9(c).
 
(d)         Reasonableness of Covenants. The Executive agrees that the scope and duration of Section 9 are reasonable and necessary to protect the Company’s legitimate business interests. If, at any time, any term or provision contained in Section 9 is finally adjudicated by a court or arbitrator of competent jurisdiction as invalid or unenforceable, the parties hereby agree that the court or arbitrator making this determination will have the power to reform the scope and/or duration of the term or provision to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable which comes closest to expressing the intention of the invalid or unenforceable term or provision; and that such reformation will not impact the other provisions of this Agreement and will be enforceable as so modified.
 
10.       Return of Property. Upon termination of Executive’s employment with the Company, or at such earlier time requested by the Company, Executive shall promptly deliver to the Company any and all Company records and any and all Company property in Executive’s possession or under Executive’s control, including without limitation manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, printouts, computer storage devices, source codes, data, tables or calculations and all copies thereof, documents that in whole or in part contain any trade secrets or confidential, proprietary or other secret information of the Company or any of its Affiliates, and all copies thereof, and keys, vehicles, access cards, access codes, passwords, credit cards, personal computers, telephones and other electronic equipment belonging to the Company or any of its Affiliates. Executive’s retention of information and materials related to Executive’s service on the Board or his personal compensation and benefits, will not violate this subsection.
 
11.        Remedies. Executive acknowledges that it would be difficult to fully compensate the Company for monetary damages resulting from any breach by Executive of the provisions of Sections 5, 6, 7, or 9 hereof. Accordingly, in the event of any actual or threatened breach of any such provisions, the Company shall, in addition to any other remedies it may have, be entitled to injunctive and other equitable relief to enforce such provisions, and such relief may be granted without the necessity of proving actual monetary damages.
 
6

12.         Miscellaneous.
 
(a)         Taxes. The Company will deduct or withhold from any payment made or benefit provided hereunder all federal, state and local taxes which the Company is required or authorized by law to deduct or withhold therefrom or otherwise collect in connection with the wages and benefits provided in connection with the Executive’s employment with the Company. This Agreement and the payments and benefits provided hereunder are intended to be exempt from the requirements of Internal Revenue Code Section 409A (and related regulations and guidance) to the maximum extent possible, whether pursuant to the short-term deferral exception described in Treasury Regulation Section 1.409A-1(b)(4), the involuntary separation pay plan exception described in Treasury Regulation Section 1.409A-1(b)(9)(iii), or otherwise. Notwithstanding anything in this Agreement to the contrary, this Agreement and the payments and benefits provided hereunder shall be interpreted, operated and administered in a manner consistent with such intentions. Without limiting the generality of the foregoing, if and to the extent required to comply with Section 409A, (i) each payment made under this Agreement shall be treated as a separate payment and the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments; (ii) any expenses eligible for reimbursement in one taxable year shall not affect the expenses eligible for reimbursement in any other taxable year, the reimbursement of an eligible expense shall be made no later than the end of the year after the year in which such expense was incurred, and the right to reimbursement shall not be subject to liquidation or exchange for another benefit; and (iii) no payment or benefit required to be paid under this Agreement on account of a termination of Executive’s employment shall be made unless and until Executive incurs a “separation from service” within the meaning of Section 409A. If Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i), then to the extent necessary to avoid subjecting Executive to the imposition of any additional tax under Section 409A with respect to amounts that are not otherwise exempt from Code 409A, amounts that would otherwise be payable under this Agreement during the six-month period immediately following a “separation from service” within the meaning of Section 409A(a)(2)(A)(i) shall not be paid during such period, but shall instead be accumulated and paid in a lump sum on the first business day following the earlier of (a) the date that is six months after the separation from service or (b) Executive’s death.
 
(b)         Jurisdiction and Venue. Executive and the Company consent to jurisdiction of the courts of the State of Minnesota and/or the federal district courts of the District of Minnesota for the purpose of resolving all issues of law, equity, or fact, arising out of or in connection with this Agreement. Any action involving claims for interpretation, breach or enforcement of this Agreement shall be brought in such courts. Each party consents to personal jurisdiction over such party in the state and/or federal courts of Minnesota and hereby waives any defense of lack of personal jurisdiction or inconvenient forum. If the decision is made to move the Company headquarters to another state, then the jurisdiction would change to the state and county in which the Company headquarters is located.

7

(c)         Governing Law. All matters relating to the interpretation, construction, application, validity and enforcement of this Agreement shall be governed by the laws of the State of Minnesota without giving effect to any choice or conflict of law provision or rule, whether of the State of Minnesota or any other jurisdiction, that would cause the application of laws of any jurisdiction other than the State of Minnesota.
 
(d)          Entire Agreement. This Agreement supersedes all prior agreements and understandings with respect to such subject matter, but does not affect, modify or supersede any other agreement between the Company and the Executive relating to the protection of confidential, proprietary or trade secret information, the assignment of inventions, non-competition with the Company or non-solicitation of customers or employees, or any document relating to Executive’s ownership rights in the Company.
 
(e)          Amendments. No amendment or modification of this Agreement shall be deemed effective unless made in writing and signed by the parties hereto.
 
(f)           No Waiver. No term or condition of this Agreement shall be deemed to have been waived, except by a statement in writing signed by the party against whom enforcement of the waiver is sought. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.
 
(g)          Assignment. Neither party may, without the written consent of the other, assign or delegate any of its rights or obligations under this Agreement, except that the Company may, without the consent of the Executive, assign or delegate any of its rights or obligations under this Agreement to (i) any corporation or other business entity with which the Company may merge or consolidate, (ii) any corporation or other business entity to which the Company may sell or transfer all or substantially all of its assets or capital stock or equity. After any such assignment or delegation by the Company, the assignee shall thereafter be deemed to be the “Company” for purposes of all terms and conditions of this Agreement and the Company shall be discharged from all further liability hereunder, but only on the condition that the assignee expressly assume all of the Company’s obligations to Executive hereunder.
 
(h)       Counterparts. This Agreement may be executed in two counterparts and delivered by facsimile or other means of electronic communication, each of which shall be deemed an original but both of which shall constitute but one instrument.
 
(i)           Notices. All notices, requests, demands or other communications required by or otherwise with respect to this Agreement shall be in writing and shall be deemed to have been duly given to the other party on the date delivered when delivered personally, one business day following the date when sent by nationally recognized overnight delivery service for next business day delivery, or three business days following the date of postmark if sent by first-class U.S. registered or certified mail, postage prepaid and return receipt requested, provided in each case such notice is properly addressed to the applicable addresses set forth below (or such other address as such party may indicate in writing to the other party pursuant to this Section 12(i)):
 
8

If to the Company:

SANUWAVE Health, Inc.
11495 Valley View Rd
Eden Prairie, MN 55344
Attention: Human Resources

If to the Executive:
At the last known address in the personnel records of the Company.

With a copy to Executive’s attorney:

(j)        Severability. To the extent that any portion of any provision of this Agreement shall be invalid or unenforceable, it shall be considered deleted herefrom and the remainder of such provision and this Agreement shall be unaffected and shall continue in full force and effect.
 
(k)         Captions and Headings. The captions and paragraph headings used in this Agreement are for convenience of reference only and shall not affect the construction or interpretation of this Agreement or any of the provisions hereof.
 
IN WITNESS WHEREOF, the undersigned have executed this Agreement on the date set forth above:
 
 
SANUWAVE HEALTH, INC.
     
 
By:
/s/ Toni Rinow
 
 
Name:
Toni Rinow
 
Title:
Chief Financial Officer
     
 
EXECUTIVE
     
 
/s/ Morgan Frank
 
 
Morgan Frank


9


Exhibit 10.2
 
TRANSITION AND SEPARATION AGREEMENT
 
This Transition and Separation Agreement (“Agreement”) is entered into by and between Kevin Richardson, II (“Employee”) and SANUWAVE Health, Inc. (the “Company”), effective as of May 23, 2023 (“Effective Date”).
 
RECITALS
 
A.          Employee has been employed by the Company as its Chief Executive Officer.
 
B.          Employee and the Company have agreed to conclude their employment relationship amicably, but mutually recognize that such a relationship may give rise to potential claims or liabilities.
 
C.          Employee and the Company desire to resolve Employee’s separation from the Company and all of Employee’s potential claims involving the Company on the terms set out in this Agreement.
 
NOW THEREFORE, in consideration of the mutual promises and provisions contained in this Agreement and the First Release, the parties, intending to be legally bound, agree as follows:

AGREEMENT
 
For the consideration described below, the adequacy of which the parties acknowledge, Employee and the Company, intending to be bound, agree as follows:
 
  1.
Continued Employment.
 
(a)           Transition Period. If Employee signs and returns this Agreement no later than May 23, 2023, and subject to the terms and conditions of this Agreement, the Company agrees to continue Employee’s employment, and Employee accepts continued employment by the Company, for the period (the “Transition Period”) commencing on the Effective Date and continuing until the earlier of (i) 12 months from the signing of this Agreement (the “Anticipated Separation Date”), or (ii) the date on which Employee’s employment is terminated under Section 1(b). The effective date of the termination of Employee’s employment with the Company for any reason is referred to herein as the “Separation Date.” Unless Employee’s employment is terminated before the Anticipated Separation Date as a result of Employee’s death or the Company terminating Employee’s employment for Cause (as defined in Section 1(c)), Employee’s employment will automatically end effective as of the end of the day on the Anticipated Separation Date.
 
If Employee does not sign and return this Agreement by May 23, 2023, then the Company will terminate Employee’s employment effective May 23, 2023, in which case such date will be the Separation Date and Employee will not be eligible for any additional compensation under this Agreement or any Employee Agreement (as defined below) and this Agreement will be null and void.


(b)           Early Termination. Employee may terminate Employee’s employment or otherwise relieve Employee of any responsibilities under this Agreement prior to the Anticipated Separation Date for any reason or for no reason, and with or without prior notice during any part of the Transition Period. Upon the termination of Employee’s employment by Employee without cause or provocation by Company, the Company will pay to Employee such compensation that has been earned but not paid to Employee as of the Separation Date, payable in accordance with the Company’s normal payroll policies and procedures.
 
(c)           Cause Definition. For purposes of this Agreement, “Cause” means (i) an act or acts of personal dishonesty taken by Employee and intended to result in substantial personal enrichment of Employee at the expense of the Company; (ii) refusal or failure by Employee to perform his employment duties as reasonably directed through the Separation Date, including without limitation, any Duties assigned to Employee as outlined below; (iii) Employee’s material breach of any employment-related agreement between Employee and the Company, including without limitation, any confidentiality, non-solicitation, non-competition, or other similar agreements (collectively, the “Employee Agreement”), this Agreement, or any material written Company policy; or (iv) the willful engaging by Employee in illegal conduct that is materially and demonstrably injurious to the Company.
 
2.           Compensation and Benefits.
 
(a)           Salary. While Employee is employed by the Company during the Transition Period, the Company will continue to pay Employee his base salary as in effect as of the Effective Date (the “Transition Salary”), payable according to the Company’s regular payroll schedule. The Transition Salary will be subject to all legally required and authorized withholdings.
 
(b)           Bonus.  While Employee is employed by the Company during the Transition Period, Employee will remain eligible for any annual bonus earned as determined by the Board (or the Compensation Committee thereof), subject to any goals or other terms of such bonus as determined by the Board.  This bonus shall be pro-rated to 5/12ths of the total to reflect the 5 months of work of Employee as CEO in 2023 and tied to the following objectives:

(i) 33.33% based on the Company achieving sales of $30 million in calendar year 2023,

(ii) 33.33% based on the Company achieving adjusted EBITDA of $3 million in calendar year 2023, and

(iii) 33.33% based on the Company achieving listing on a major exchange (defined as NASDAQ or NYSE) in calendar year 2023

(c)           Benefits. While Employee is employed by the Company during the Transition Period, Employee shall remain eligible to participate in all employee benefit plans and programs generally available from time to time to employees of the Company, to the extent that Employee meets the eligibility requirements for each individual plan or program and subject to the provisions, rules, and regulations of, or applicable to, the plan or program.


(d)           Stock Options.  The Employee is entitled to 25,000,000 options granted by the Board on April 6, 2023, 50% of which will vest immediately upon issuance and 50% of which will vest on April 15, 2024.  For the avoidance of doubt, the parties expressly agree that the Company will waive any provision that the options must be exercised within 90 days of separation from the Company.  Options shall remain valid through their standard 5-year term per employee options agreement.
 
(e)           No Additional Compensation. Except as set forth in Sections 2(a), 2(b), 2(c), 2(d), or 5(a)(iii) or as expressly determined in the Company’s sole discretion, Employee will not be eligible to receive any other form of compensation of any kind during the Transition Period, including without limitation, any other bonuses or other incentive compensation, commissions, equity awards or equity-based compensation in any form.

3.           Position, Duties, Responsibilities and Authority. During the Transition Period, Employee shall be employed as the Chief Strategy Officer and shall report to the interim Chief Executive Officer.  Employee shall have the following duties, responsibilities and authority (collectively, “Duties”):

(a)           ensure the successful onboarding of the non-interim Chief Executive Officer and Chief Operations Officer placements through open communication, knowledge transfer and cooperation with all cross functional teams;

(b)           provide and openly share with successors all historical information relating to company procedures, IP, departmental operations, KOL’s, customers, institutions, studies, trade secrets and company history;

(c)           facilitate introductions and continue interaction with key customers, vendors and other important industry contacts;

(d)           represent the Company at trade shows and other industry functions as requested;

(e)           identify joint ventures and strategic partnerships to monetize the Company’s patent portfolio; and

(f)           other deliverables as identified by the interim or non-interim Chief Executive Officer.

Employee shall perform the Duties to the best of his abilities and working toward the best interests of the Company at all times, including without limitation, not disparaging the Company, its products, services, employees, officers, directors, or agents.

Other than participation in Boards of Directors of companies that are not in competition with Company, such participation to be disclosed by Employee to the Board of Directors, during the Transition Period, Employee shall devote Employee’s full working time, attention and efforts satisfying Employee’s Duties, subject to Employee’s reasonable use of vacation leave during the Transition Period; provided, however, that the Company may, at any time and for any reason, relieve Employee of some or all of Employee’s Duties during any part of the Transition Period. Upon the termination of Employee’s employment for any reason, Employee shall follow all applicable policies and procedures previously adopted by the Company or adopted by the Company during the Transition Period, including without limitation policies related to business ethics, non-discrimination, conflict of interest, confidentiality and protection of trade secrets, to the extent Employee’s obligations survive the Separation Date, and Employee shall not engage in any activity during the Transition Period that is detrimental or is reasonably likely to be detrimental to the Company’s best interests or that violates any terms of the Employee Agreement.
 

4.           First Release. At the same time Employee signs this Agreement, Employee also will sign a release in the form attached to this Agreement as Exhibit A (the “First Release”). This Agreement will not be interpreted or construed to limit the First Release in any manner. The existence of any dispute respecting the interpretation of this Agreement or the alleged breach of this Agreement will not nullify or otherwise affect the validity or enforceability of the First Release. The periods described in the First Release during which Employee may consider whether to sign or may rescind the First Release and the procedures stated in the First Release for accepting or rescinding the First Release also apply to this Agreement. The First Release and this Agreement must be accepted or rescinded together.
 
5.           Separation Benefits.
 
(a)        Payment. Subject to satisfaction of the conditions set forth in Section 5(b), the Company will provide the following separation benefits to Employee (combined, the “Separation Benefits”):
 
(i)      the Company and Employee will enter into a: (1) new, mutually acceptable employment agreement; incorporating the provisions set forth in Section 2 above, or (2) a consulting agreement under which he will continue to provide services to the Company for a period of up to two years following the end of the Transition Period which will be for mutually agreed upon services and compensation between the Employee and the Company and incorporating the provisions set forth in Section 2(a), 2(b), and 2(d) above, or (3) a severance payment as set forth in Section 5(a)(iii) below, which preserves Employee’s stock option grant as identified in Section 2(d) above; and

  (ii)     if Employee properly elects continuation coverage under SANUWAVE’s group health insurance policies, continuation of the Company’s contributions (at the then applicable rate for similar situated employees of SANUWAVE) for the period beginning on the Separation Date and ending on the earlier of (A) the two-year anniversary of the Separation Date,  (B) the date on which Employee becomes eligible for health insurance benefits through a subsequent employer, and (C) the date Employee is no longer legally eligible to receive such continuation coverage.
 
(iii)  In the event that no mutually agreed upon consulting agreement or further employment contract is signed between Employer and Employee, or in the event Employee’s employment or consulting engagement is terminated prior to the Anticipated Separation date by the Company without Cause, Employee will be eligible to receive a severance payment equal to (A) 20 weeks of his final base salary, and (B) all earned by unpaid compensation owed by the Company to Employee under applicable law.

In addition to all Separation Benefits, the Company will pay to Employee all amounts required to be paid by applicable state law including, but not limited to, unreimbursed business expenses submitted to the Company by the close of business on June 30, 2023 and accrued and unused paid time off.


(b)       Conditions. The Separation Benefits described in Section 5(a) are subject to the following conditions: (i) Employee remains employed by or consultant to the Company through the Anticipated Separation Date or the date during the Transition Period upon which the Company terminates Employee’s employment prior to the Anticipated Separation Date without Cause, (ii) on or within 21 days after the Separation Date, Employee has signed a second release in the form substantially as attached hereto as Exhibit B (the “Second Release”); (iii) Employee has not rescinded the Second Release within the rescission period set forth in the Second Release; and (iv) Employee has not breached his obligations under this Agreement or the Employee Agreement. This Agreement will not be interpreted or construed to limit the Second Release in any manner. The existence of any dispute respecting the interpretation of this Agreement or the alleged breach of this Agreement will not nullify or otherwise affect the validity or enforceability of the Second Release.
 
6.           Return of Property. Upon the Separation Date, or at any earlier time upon request from the Company, Employee shall deliver promptly to the Company all the Company property that is in Employee’s possession or under Employee’s control, including without limitation any computers, cellular phone, pagers, credit cards, keys, records, files, documents, data, photographs, video tapes, audio tapes, computer disks and other computer storage media.
 
7.           Confidentiality and Non-Disparagement. Employee shall keep the terms of this Agreement, the First Release and the Second Release confidential and shall not disclose such terms to anyone other than Employee’s attorneys, accountants, tax advisors, or spouse, and except as required or authorized by law. Employee agrees that Employee, and Company agrees that the Board will not make any false, disparaging, derogatory or offensive statements to anyone about the other (or, in the case of the Employee, about any of the Company’s products or services). Notwithstanding any language above to the contrary, nothing in this Agreement is intended to, and does not, interfere with Employee’s rights under federal, state or local civil rights or discrimination laws to file a charge of discrimination with the Equal Employment Opportunity Commission or any similar state or local administrative agency, to participate in any investigation or proceeding conducted by the Equal Employment Opportunity Commission or any similar state or local agency, to discuss wages, benefits, and other terms and conditions of employment or workplace matters of mutual concern to the extent such discussions are protected by the National Labor Relations Act, or to provide truthful, non-trade secret information in response to any subpoena or other legal process.
 
8.           Agreement to Assist and Cooperate. At the Company’s reasonable request and upon reasonable notice, Employee will, from time to time, following the Transition Period, discuss and consult with the Company regarding business matters that Employee was directly and substantially involved with while employed by the Company.

9.           Entire Agreement; Amendment. This Agreement (including the First Release and Second Release) constitutes the entire agreement between the parties with respect to the subject matter of this Agreement (including the First Release and Second Release), including the termination of Employee’s employment with the Company, and the Company and Employee agree that there were no inducements or representations leading to the execution of this Agreement except as stated in this Agreement, the First Release and the Second Release. This Agreement may be amended only by a writing signed by Employee and the Company.


10.         Assignment. The rights and obligations of the Company under this Agreement (including the First Release and Second Release) shall inure to the benefit of and shall be binding upon its agents, employees, successors, assigns, heirs, attorneys, trustees, estates and representatives. The rights and obligations of Employee under this Agreement shall not be subject to transfer or assignment by Employee without the written consent of the Company.

11.         Governing Law and Consent to Jurisdiction. This Agreement, the First Release and the Second Release shall be interpreted and construed in accordance with the laws of Minnesota (without regard to conflict of laws principles). Any legal action related to or arising out of this Agreement, the First Release and the Second Release shall be commenced exclusively in a state or federal court in Minnesota. The parties hereby consent to jurisdiction in the state or federal courts located in Minnesota and waive any defense based on lack of jurisdiction or inconvenient forum.

Dated: 5/23/2023 , 2023
 /s/ Kevin Richardson, II
 
Kevin Richardson, II
   
Dated: 5/23/2023 , 2023
SANUWAVE
   
 
By:
Morgan Frank
     
 
Its:
ceo/chairman
 

EXHIBIT A
 
FIRST RELEASE BY KEVIN RICHARDSON
 
Definitions. I intend all words used in this First Release (“Release”) to have their plain meanings in ordinary English. Specific terms that I use in this Release have the meanings outlined below.  Any capitalized terms not defined in this Release shall have the meaning set forth in the Separation Agreement (as defined below).


A.
I, me, and my means me (Kevin Richardson, II) and anyone who has or obtains any legal rights or claims through me.


B.
SANUWAVE means SANUWAVE Health, Inc., any entity related to SANUWAVE Health, Inc. in the present or past (including without limitation, its predecessors, parents, subsidiaries, members, affiliates, and divisions) and any successors of SANUWAVE Health, Inc.


C.
Company means SANUWAVE; the present and past officers, directors, members, committees, equity holders (together with any officers, partners, managers members, employees, agents and affiliates of any such equity holder), and employees of SANUWAVE; any company providing employment or employee benefit services to SANUWAVE in the past or present; any company providing insurance to SANUWAVE in the present or past; the present and past employee benefit plans sponsored or maintained by SANUWAVE (other than multiemployer plans) and the present and past fiduciaries of such plans; the attorneys for SANUWAVE; and anyone who acted on behalf of SANUWAVE or on instructions from SANUWAVE.


D.
Separation Agreement means the Transition and Separation Agreement between me and SANUWAVE dated May 23, 2023.


E.
Consideration means the separation benefits as outlined in the Separation Agreement.


F.
My Claims means all of my rights that I now have to any relief of any kind from the Company, including without limitation:


1.
all claims arising out of or relating to my employment with SANUWAVE, the decision to terminate that employment, or the termination of that employment;


2.
all claims arising out of or relating to the statements, actions, or omissions of the Company;


3.
all claims arising out of or relating to any agreements (whether express or implied) to which I and the Company are parties;



4.
all claims for any alleged unlawful discrimination, harassment, retaliation or reprisal, or other alleged unlawful practices arising under any federal, state, or local statute, ordinance, or regulation, including without limitation, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act and the ADA Amendments Act, the Rehabilitation Act of 1973, 42 U.S.C. § 1981, the Employee Retirement Income Security Act, the Family Medical Leave Act, the Lilly Ledbetter Fair Pay Act of 2009, the Worker Adjustment and Retraining Notification Act, the Fair Credit Reporting Act, the Genetic Information Nondiscrimination Act, the Massachusetts Wage Act (M.G.L. 149, §§ 148 to 150), the Massachusetts Fair Employment Practices Act (M.G.L. 151B, §§ 1 to 10), the Massachusetts Small Necessities Leave Act;,the Massachusetts Earned Sick Time Law, the Massachusetts Equal Pay Act, the Massachusetts Act Relative to Insurance and Genetic Testing and Privacy Protection, the Massachusetts Parental Leave Act, the Massachusetts Sexual Harassment Statute, the Massachusetts Civil Rights Act, the Massachusetts Equal Rights Act, the Massachusetts Minimum Fair Wage Act, the Massachusetts Plant Closing Law, the Massachusetts False Claims Act, the Massachusetts Act Relative to Domestic Violence, and any workers’ compensation retaliation claims;


5.
all claims for alleged wrongful discharge; breach of contract; breach of implied contract; failure to keep any promise; breach of a covenant of good faith and fair dealing; breach of fiduciary duty; estoppel; defamation; infliction of emotional distress; fraud; misrepresentation; negligence; harassment; retaliation or reprisal; constructive discharge; assault; battery; false imprisonment; invasion of privacy; interference with contractual or business relationships; any other wrongful employment practices; and violation of any other principle of common law;


6.
all claims for compensation of any kind, including without limitation, bonuses, commissions, equity awards or equity-based compensation in any form, vacation pay, perquisites, and expense reimbursements;
 

7.
all claims for back pay, front pay, reinstatement, other equitable relief, compensatory damages, damages for alleged personal injury, liquidated damages, and punitive damages;


8.
all claims that a past unlawful decision has or has had a continuing effect on my compensation; and



9.
all claims for attorneys’ fees, costs, and interest.

However, My Claims do not include (i) any claims for breach of the Separation Agreement, (ii) any claims for unemployment benefits, (iii) any claims I have to any amounts under SANUWAVE’s 401(k) plan, (iv) any claims that the law does not allow to be waived, (v) any claims for indemnification I may have as an officer or director based on my service to the Company under the Company’s governing documents, applicable law, or any insurance policy of the Company, or (vi) any claims that may arise after the date on which I sign this Release.

Agreement to Release My Claims. Subject to the conditions outlined below, I will receive the Consideration from SANUWAVE if I sign and do not rescind this Release as provided below.  I understand and acknowledge that this Consideration is in addition to anything of value that I would be entitled to receive from SANUWAVE if I did not sign this Release or if I rescinded this Release.  In exchange for that Consideration I give up and release all of My Claims as set forth in this Release.  I will not make any demands or claims against the Company for compensation or damages relating to My Claims.  The Consideration that I am receiving is a fair compromise for the release of My Claims.  Furthermore, I understand and agree that, with the exception of money provided to me by a governmental agency as an award for providing information, I am not entitled to receive any money or other relief in connection with My Claims, regardless of who initiated or filed the charge or other proceeding.

Acknowledgment of Compensation. SANUWAVE will provide me amounts owed under the Separation Agreement, my regular base compensation through the Separation Date, and any other compensation that is earned but unpaid as of the Separation Date. Upon receipt of such amounts, I represent and confirm that I have been fully paid for all wages, overtime, commissions, bonuses, and other compensation that I have earned through my employment with SANUWAVE through the date of this Release.

No Other Rights To Compensation.  I understand and acknowledge that, except as provided in this Release and the Separation Agreement, and subject to the terms and conditions of this Release and the Separation Agreement, the Company is not obligated to make any payments to me of any kind and does not have any other outstanding obligations to me under any agreement or arrangement between me and the Company or under any Company plan or policy.

Additional Agreements and Understandings.  Even though SANUWAVE will provide Consideration for me to settle and release My Claims, the Company does not admit that it is responsible or legally obligated to me.  In fact, the Company denies that it is responsible or legally obligated to me for My Claims, denies that it engaged in any unlawful or improper conduct toward me, and denies that it treated me unfairly.

ConfidentialityTo the fullest extent permitted by law, I agree that the terms of this Release are confidential and that I may not disclose those terms to any person except: (a) as part of any legal or administrative agency proceeding; or (b) to my attorneys, spouse,  and tax advisors, provided they agree to keep the terms of this Release confidential.

Non-Disclosure of Confidential Information. Except as permitted above with respect to limited disclosure of the terms of this Release to certain individuals, I will not use or disclose any confidential information (as outlined in any employment-related agreement between me and SANUWAVE (“Employee Agreement”)) to any person at any time unless I have the advance written consent of SANUWAVE’s Board of Directors.  My prohibited use or disclosure of confidential information will not apply if I can establish that the confidential information has become publicly available and easily ascertainable through no wrongful act or omission by me.  I acknowledge the Consideration for which I am eligible under this Release is conditioned upon me complying with the Employee Agreement, including my obligation to return all company information upon the separation of my employment.


No Unlawful Restriction.  I understand and agree that nothing in this Release, including the Confidentiality and Non-Disclosure of Confidential Information provisions above, is intended to or will: (a) impose any condition, penalty, or other limitation on my rights to challenge this Release; (b) constitute an unlawful release of my rights; (c) prevent me from exercising any rights I have under Section 7 of the National Labor Relations Act; or (d) prevent or interfere with my ability or right to provide truthful testimony if under subpoena to do so, to file any charge with or participate in any investigation or proceeding before the U.S. Equal Employment Opportunity Commission or any other federal, state or local governmental agency, or to respond to a subpoena, court order or as otherwise provided by law.

CooperationIn partial consideration for the Consideration being paid to me under this Release, to the fullest extent permitted by law, I agree to cooperate with the Company’s reasonable requests, subject to my own availability, in: (a) providing information; (b) resolving questions; or (c) transitioning any responsibilities of information, pertaining to any matters which arose during my employment by SANUWAVE about which I have or may have knowledge of the underlying facts or for which I had responsibility during my employment with SANUWAVE.

Return Of Property.  I represent that I have delivered to SANUWAVE all SANUWAVE property that was previously in my possession or under my control, including without limitation any computers, cellular telephones, credit cards, keys, records, files, documents, data, computer disks and other computer storage media.

Procedure for Accepting or Rescinding the Release.  To accept the terms of this Release, I must deliver this Release, after I have signed and dated it, to SANUWAVE by email or by mail within the period that I have to consider this Release.  All deliveries must be made to SANUWAVE at the following address:

 
SANUWAVE
 
Attn: Human Resources
 
11495 Valley View Road
 
Eden Prairie, MN 55344-3617
  [***]

If I choose to deliver my acceptance by mail, it must be (1) postmarked within the period stated above; and (2) properly addressed to SANUWAVE at the address stated above.

Entire Agreement.  This Release, together with the Separation  Agreement, constitutes the entire agreement between me and SANUWAVE with respect to the subject matter of this Release, including the termination of my employment with SANUWAVE, and I agree that there were no inducements or representations leading to the execution of this Release except as stated in this Release and the Separation Agreement. For avoidance of doubt, this Release does not modify or supersede any of the terms of the Employee Agreement, which will remain in full force and effect in accordance with the terms of the Employee Agreement.


Amendment.  This Release may be amended only by a writing that is signed by me and an authorized representative of SANUWAVE.

Waiver. No term or condition of this Release shall be deemed to have been waived except by a statement in writing signed by the party against whom the enforcement of the waiver is sought. The waiver by SANUWAVE of the breach or nonperformance of any provision of this Release by me will not operate or be construed as a waiver of any future breach or nonperformance under any such provision of this Release.

Severability. In case any one or more of the provisions of this Release is determined invalid, illegal, or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained in this Release will not in any way be affected or impaired thereby.

Heirs, Successors, and Assigns. This Release shall be binding upon me and my heirs, administrators, representatives, or executors, and upon SANUWAVE’s successors or assigns. No assignment of this Release may be made by me, and any such purported assignment shall be null and void.  SANUWAVE may assign its rights or obligations under this Release to any successor or assign of SANUWAVE without further consent by me.

Interpretation of the Release.  This Release should be interpreted as broadly as possible to achieve my intention to resolve all of My Claims against the Company.  If this Release is held by a court to be inadequate to release a particular claim encompassed within My Claims, this Release will remain in full force and effect with respect to all the rest of My Claims.

My Representations.  I am legally able and entitled to receive the Consideration being provided to me in settlement of My Claims.  I have not been involved in any personal bankruptcy or other insolvency proceedings at any time since I began my employment with SANUWAVE.  No child support orders, garnishment orders, or other orders requiring that money owed to me by SANUWAVE be paid to any other person are now in effect.

I acknowledge and agree that I have received all leave, leaves of absence, and leave benefits and protections for which I am eligible, and have not suffered any on-the-job injury for which you have not already notified the Company.

I have read this Release carefully.  I understand all of its terms.  In signing this Release, I have not relied on any statements or explanations made by the Company except as specifically set forth in this Release.  I am voluntarily releasing My Claims against the Company.  I intend this Release to be legally binding.

Dated:
   

   
KEVIN RICHARDSON, II

EXHIBIT B
 
SECOND RELEASE BY KEVIN RICHARDSON

Definitions. I intend all words used in this Second Release (“Release”) to have their plain meanings in ordinary English. Specific terms that I use in this Release have the meanings outlined below.  Any capitalized terms not defined in this Release shall have the meaning set forth in the Separation Agreement (as defined below).


A.
I, me, and my means me (Kevin Richardson, II) and anyone who has or obtains any legal rights or claims through me.


B.
SANUWAVE means SANUWAVE Health, Inc., any entity related to SANUWAVE Health, Inc. in the present or past (including without limitation, its predecessors, parents, subsidiaries, members, affiliates, and divisions) and any successors of SANUWAVE Health, Inc.


C.
Company means SANUWAVE; the present and past officers, directors, members, committees, equity holders (together with any officers, partners, managers members, employees, agents and affiliates of any such equity holder), and employees of SANUWAVE; any company providing employment or employee benefit services to SANUWAVE in the past or present; any company providing insurance to SANUWAVE in the present or past; the present and past employee benefit plans sponsored or maintained by SANUWAVE (other than multiemployer plans) and the present and past fiduciaries of such plans; the attorneys for SANUWAVE; and anyone who acted on behalf of SANUWAVE or on instructions from SANUWAVE.


D.
Separation Agreement means the Transition and Separation Agreement between me and SANUWAVE dated May 23, 2023.


E.
Consideration means the separation consideration as outlined in the Separation Agreement.


F.
My Claims means all of my rights that I now have to any relief of any kind from the Company, including without limitation:


1.
all claims arising out of or relating to my employment with SANUWAVE, the decision to terminate that employment, or the termination of that employment;


2.
all claims arising out of or relating to the statements, actions, or omissions of the Company;


3.
all claims arising out of or relating to any agreements (whether express or implied) to which I and the Company are parties;



4.
all claims for any alleged unlawful discrimination, harassment, retaliation or reprisal, or other alleged unlawful practices arising under any federal, state, or local statute, ordinance, or regulation, including without limitation, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act and the ADA Amendments Act, the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, the Rehabilitation Act of 1973, 42 U.S.C. § 1981, the Employee Retirement Income Security Act, the Family Medical Leave Act, the Lilly Ledbetter Fair Pay Act of 2009, the Worker Adjustment and Retraining Notification Act, the Fair Credit Reporting Act, the Genetic Information Nondiscrimination Act, the Massachusetts Wage Act (M.G.L. 149, §§ 148 to 150), the Massachusetts Fair Employment Practices Act (M.G.L. 151B, §§ 1 to 10), the Massachusetts Small Necessities Leave Act;,the Massachusetts Earned Sick Time Law, the Massachusetts Equal Pay Act, the Massachusetts Act Relative to Insurance and Genetic Testing and Privacy Protection, the Massachusetts Parental Leave Act, the Massachusetts Sexual Harassment Statute, the Massachusetts Civil Rights Act, the Massachusetts Equal Rights Act, the Massachusetts Minimum Fair Wage Act, the Massachusetts Plant Closing Law, the Massachusetts False Claims Act, the Massachusetts Act Relative to Domestic Violence, and any workers’ compensation retaliation claims;


5.
all claims for alleged wrongful discharge; breach of contract; breach of implied contract; failure to keep any promise; breach of a covenant of good faith and fair dealing; breach of fiduciary duty; estoppel; defamation; infliction of emotional distress; fraud; misrepresentation; negligence; harassment; retaliation or reprisal; constructive discharge; assault; battery; false imprisonment; invasion of privacy; interference with contractual or business relationships; any other wrongful employment practices; and violation of any other principle of common law;


6.
all claims for compensation of any kind, including without limitation, bonuses, commissions, equity awards or equity-based compensation in any form, vacation pay, perquisites, and expense reimbursements;
 


7.
all claims for back pay, front pay, reinstatement, other equitable relief, compensatory damages, damages for alleged personal injury, liquidated damages, and punitive damages;


8.
all claims that a past unlawful decision has or has had a continuing effect on my compensation; and



9.
all claims for attorneys’ fees, costs, and interest.

However, My Claims do not include (i) any claims for breach of the Separation Agreement, (ii) any claims for unemployment benefits, (iii) any claims I have to any amounts under SANUWAVE’s 401(k) plan, (iv) any claims that the law does not allow to be waived, (v) any claims for indemnification I may have as an officer or director based on my service to the Company under the Company’s governing documents, applicable law, or any insurance policy of the Company, or (vi) any claims that may arise after the date on which I sign this Release.

Agreement to Release My Claims. Subject to the conditions outlined below, I will receive the Consideration from SANUWAVE if I sign and do not rescind this Release as provided below.  I understand and acknowledge that this Consideration is in addition to anything of value that I would be entitled to receive from SANUWAVE if I did not sign this Release or if I rescinded this Release.  In exchange for that Consideration I give up and release all of My Claims as set forth in this Release.  I will not make any demands or claims against the Company for compensation or damages relating to My Claims.  The Consideration that I am receiving is a fair compromise for the release of My Claims.  Furthermore, I understand and agree that, with the exception of money provided to me by a governmental agency as an award for providing information, I am not entitled to receive any money or other relief in connection with My Claims, regardless of who initiated or filed the charge or other proceeding.

Acknowledgment of Compensation. SANUWAVE will provide me amounts owed under the Separation Agreement, my regular base compensation through the Separation Date, and any other compensation that is earned but unpaid as of the Separation Date. Upon receipt of such amounts, I represent and confirm that I have been fully paid for all wages, overtime, commissions, bonuses, and other compensation that I have earned through my employment with SANUWAVE through the date of this Release.

No Other Rights To Compensation.  I understand and acknowledge that, except as provided in this Release and the Separation Agreement, and subject to the terms and conditions of this Release and the Separation Agreement, the Company is not obligated to make any payments to me of any kind and does not have any other outstanding obligations to me under any agreement or arrangement between me and the Company or under any Company plan or policy.

Additional Agreements and Understandings.  Even though SANUWAVE will provide Consideration for me to settle and release My Claims, the Company does not admit that it is responsible or legally obligated to me.  In fact, the Company denies that it is responsible or legally obligated to me for My Claims, denies that it engaged in any unlawful or improper conduct toward me, and denies that it treated me unfairly.

ConfidentialityTo the fullest extent permitted by law, I agree that the terms of this Release are confidential and that I may not disclose those terms to any person except: (a) as part of any legal or administrative agency proceeding; or (b) to my attorneys, spouse and tax advisors, provided they agree to keep the terms of this Release confidential.


Non-Disclosure of Confidential Information. Except as permitted above with respect to limited disclosure of the terms of this Release to certain individuals, I will not use or disclose any confidential information (as outlined in any employment-related agreement between me and SANUWAVE (“Employee Agreement”)) to any person at any time unless I have the advance written consent of SANUWAVE’s Board of Directors.  My prohibited use or disclosure of confidential information will not apply if I can establish that the confidential information has become publicly available and easily ascertainable through no wrongful act or omission by me.  I acknowledge the Consideration for which I am eligible under this Release is conditioned upon me complying with the Employee Agreement, including my obligation to return all company information upon the separation of my employment.

No Unlawful Restriction.  I understand and agree that nothing in this Release, including the Confidentiality and Non-Disclosure of Confidential Information provisions above, is intended to or will: (a) impose any condition, penalty, or other limitation on my rights to challenge this Release; (b) constitute an unlawful release of my rights; (c) prevent me from exercising any rights I have under Section 7 of the National Labor Relations Act; or (d) prevent or interfere with my ability or right to provide truthful testimony if under subpoena to do so, to file any charge with or participate in any investigation or proceeding before the U.S. Equal Employment Opportunity Commission or any other federal, state or local governmental agency, or to respond to a subpoena, court order or as otherwise provided by law.

Response to Reference Requests. I agree to direct any reference requests related to my employment with SANUWAVE to SANUWAVE’s Human Resources Department. SANUWAVE agrees to respond to any such requests by providing only my dates of employment with SANUWAVE and the positions I held during such employment.

CooperationIn partial consideration for the Consideration being paid to me under this Release, to the fullest extent permitted by law, I agree to cooperate with the Company’s reasonable requests, subject to my own availability, in: (a) providing information; (b) resolving questions; or (c) transitioning any responsibilities of information, pertaining to any matters which arose during my employment by SANUWAVE about which I have or may have knowledge of the underlying facts or for which I had responsibility during my employment with SANUWAVE.

Return Of Property.  I represent that I have delivered to SANUWAVE all SANUWAVE property that was previously in my possession or under my control, including without limitation any computers, cellular telephones, credit cards, keys, records, files, documents, data, computer disks and other computer storage media.

Advice to Consult with an Attorney. I understand and acknowledge that I am hereby being advised by the Company to consult with an attorney prior to signing this Release.  My decision whether to sign this Release is my own voluntary decision made with full knowledge that the Company has advised me to consult with an attorney.

Period to Consider the Release. I understand that I have twenty-one (21) days after the day I receive this Release or my Separation Date, whichever is later, to consider whether I wish to sign this Release.  I may not sign this Release before my Separation Date.  If I sign this Release before the end of the 21-day consideration period, it will be my voluntary decision to do so because I have decided that I do not need any additional time to decide whether to sign this Release.  I also agree that any changes made to this Release before I sign it, whether material or immaterial, will not restart the 21-day consideration period.


My Right to Rescind this Release.  I understand that I may rescind this Release at any time within fifteen (15) days after I sign it, not counting the day upon which I sign it.  This Release will not become effective or enforceable unless and until the 15-day rescission period has expired without my rescinding it.

Procedure for Accepting or Rescinding the Release.  To accept the terms of this Release, I must deliver this Release, after I have signed and dated it, to SANUWAVE by email or by mail within the 21-day period that I have to consider this Release.  To rescind my acceptance, I must deliver a written, signed statement that I rescind my acceptance to SANUWAVE by email or by mail within the 21-day rescission period.  All deliveries must be made to SANUWAVE at the following address:

 
SANUWAVE
 
Attn: Human Resources
 
11495 Valley View Road
 
Eden Prairie, MN 55344-3617
 
[***]

If I choose to deliver my acceptance or the rescission of my acceptance by mail, it must be (1) postmarked within the period stated above; and (2) properly addressed to SANUWAVE at the address stated above.

Entire Agreement.  This Release, together with the Separation Agreement and the First Release, constitutes the entire agreement between me and SANUWAVE with respect to the subject matter of this Release, including the termination of my employment with SANUWAVE, and I agree that there were no inducements or representations leading to the execution of this Release except as stated in this Release, the Separation Agreement and the First Release. For avoidance of doubt, this Release does not modify or supersede any of the terms of the Employee Agreement, which will remain in full force and effect in accordance with the terms of the Employee Agreement.

Amendment.  This Release may be amended only by a writing that is signed by me and an authorized representative of SANUWAVE.

Waiver. No term or condition of this Release shall be deemed to have been waived except by a statement in writing signed by the party against whom the enforcement of the waiver is sought. The waiver by SANUWAVE of the breach or nonperformance of any provision of this Release by me will not operate or be construed as a waiver of any future breach or nonperformance under any such provision of this Release.

Governing Law and Jurisdiction. This Release shall be governed by and interpreted in accordance with the laws of the State of Minnesota, without regard to conflicts of law provisions. Minnesota state or federal courts will have personal and subject-matter jurisdiction over any litigation arising out of or relating to this Release. Any action involving claims for interpretation, breach or enforcement of this Release shall be brought in such courts.  I consent to personal jurisdiction over me in the state and/or federal courts of Minnesota and hereby waive any defense of lack of personal jurisdiction or inconvenient forum.


Severability. In case any one or more of the provisions of this Release is determined invalid, illegal, or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained in this Release will not in any way be affected or impaired thereby.

Heirs, Successors, and Assigns. This Release shall be binding upon me and my heirs, administrators, representatives, or executors, and upon SANUWAVE’s successors or assigns. No assignment of this Release may be made by me, and any such purported assignment shall be null and void.  SANUWAVE may assign its rights or obligations under this Release to any successor or assign of SANUWAVE without further consent by me.

Interpretation of the Release.  This Release should be interpreted as broadly as possible to achieve my intention to resolve all of My Claims against the Company.  If this Release is held by a court to be inadequate to release a particular claim encompassed within My Claims, this Release will remain in full force and effect with respect to all the rest of My Claims.

My Representations.  I am legally able and entitled to receive the Consideration being provided to me in settlement of My Claims.  I have not been involved in any personal bankruptcy or other insolvency proceedings at any time since I began my employment with SANUWAVE.  No child support orders, garnishment orders, or other orders requiring that money owed to me by SANUWAVE be paid to any other person are now in effect.

I acknowledge and agree that I have received all leave, leaves of absence, and leave benefits and protections for which I am eligible, and have not suffered any on-the-job injury for which you have not already notified the Company.

I have read this Release carefully.  I understand all of its terms.  In signing this Release, I have not relied on any statements or explanations made by the Company except as specifically set forth in this Release.  I am voluntarily releasing My Claims against the Company.  I intend this Release to be legally binding.

Dated:
   

   
KEVIN RICHARDSON, II




Exhibit 99.1


SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer
 
Published: May 24, 2023
 
Frank brings 29 years of experience in life sciences, technology, and capital markets.  Kevin Richardson to remain at SANUWAVE as Chief Strategic Officer and as a member of the Board of Directors.

Eden Prairie, MN /  May 24, 2023/ SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB:SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that its Board of Directors has appointed Morgan Frank as Chief Executive Officer. Frank, a company development, corporate restarts, and capital markets veteran, has served 19 years as founder and principal of Manchester Management (Manchester Explorer Fund), the Company’s largest outside shareholder and has served as Chairman of the SANUWAVE Board of Directors since August 2022.  Kevin Richardson, the Company’s former CEO, will remain on the Board of Directors of the Company and continue an active role in the Company, serving as its Chief Strategic Officer during this exciting period of growth and opportunity for the Company.

“Having now been SANUWAVE’s Chairman for nearly a year, I believe strongly in the Company and its mission to bring efficacious and cost-effective technology to the wound care market,” said Frank. “This is a very exciting time in our lifecycle as we seek to rapidly expand our manufacturing and explore and expand our commercial and strategic options.  I would like to thank Kevin for his role in assembling this impressive product suite and setting the stage for future success.”
 
Before joining the Company, Frank, 51, has served 19 years as principal at Manchester Management LLC, the Company’s largest outside shareholder. He brings with him 29 years of U.S. public equity and capital markets experience, with a focus in life sciences and technology as well as corporate restarts and intellectual property salvage and monetization. Mr. Frank has provided long term strategic planning, due diligence and business development strategy, and investor relations guidance to over 100 public companies and looks forward to working more deeply with SANUWAVE.
 
About SANUWAVE
 
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
 
SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
 

Forward-Looking Statements
 
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.